New hope for tough blood cancers? early trial launches
NCT ID NCT07572006
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental drug called JNJ-95804306 in people with blood cancers like leukemia that have come back or not responded to standard treatments. The study has two parts: first, finding a safe dose, and then checking if the drug shrinks tumors when used alone or with standard care. About 280 participants will take part across multiple sites.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
JNJ-95804306
What this could lead to
If successful, this could point toward a new treatment option for people with blood cancers that have not responded to other therapies.
What could go wrong
This is an early Phase 1 trial, so the drug may not be effective or may cause serious side effects. It is also small and focused on safety, not proof of benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana Blood & Marrow Transplantation
RECRUITINGIndianapolis, Indiana, 46237, United States
-
Rutgers Cancer Institute of New Jersey
RECRUITINGPiscataway, New Jersey, 08854, United States
-
Start Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States